Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s BioMarin Pharmaceuticals BMRN Stock Holding History

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-53,087	Closed	-$5.12M	–	947
2023 Q4	$5.12M	Buy	+53,087	New	+$4.7M	0.02%	424
2023 Q3	–	Sell	-8,894	Closed	-$771K	–	1019
2023 Q2	$771K	Buy	+8,894	New	+$837K	﹤0.01%	812
2023 Q1	–	Sell	-34,000	Closed	-$3.52M	–	1263
2022 Q4	$3.52M	Sell	34,000 -7,000	-17%	-$657K	0.02%	563
2022 Q3	$3.48M	Buy	+41,000	New	+$3.65M	0.02%	521
2022 Q2	–	Sell	-109	Closed	-$8K	–	1572
2022 Q1	$8K	Hold	109	–	–	﹤0.01%	1632
2021 Q4	$10K	Sell	109 -57,378	-100%	-$4.73M	﹤0.01%	1626
2021 Q3	$4.44M	Buy	57,487 +33,000	+135%	+$2.6M	0.01%	577
2021 Q2	$2.04M	Buy	24,487 +24,378	+22,365%	+$1.93M	﹤0.01%	1001
2021 Q1	$8K	Sell	109 -869	-89%	-$71K	﹤0.01%	1494
2020 Q4	$86K	Buy	+978	New	+$77.5K	﹤0.01%	1305

Other funds holding BMRN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's BMRN Position: Q1 2024 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold out of BioMarin Pharmaceuticals (BMRN) in Q1 2024, closing a stake of 53,087 shares — an estimated $5.12M sold.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in BMRN in Q4 2020 and held it in 10 quarters. The position peaked at $5.12M in Q4 2023. 561 funds tracked by Wall St. Rank hold BMRN as of Q1 2024.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund reported no remaining BioMarin Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold 53,087 BioMarin Pharmaceuticals shares in Q1 2024, an estimated $5.12M.
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in BioMarin Pharmaceuticals in Q4 2020 and held it in 10 quarters.
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's BioMarin Pharmaceuticals position peaked at $5.12M in Q4 2023.
561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2024.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q1 2024, filed 13 May 2024.